Registration Dossier
Registration Dossier
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 233-487-5 | CAS number: 10196-49-3
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 969
- Report date:
- 1969
Materials and methods
- Principles of method if other than guideline:
- - Principle of test: similar to standard acute method (not further specified)
- Short description of test conditions: 15 male and 15 female rats were applied by gavage the test substance in doses up to 2500 mg/kg bw
- Parameters analysed / observed: deaths and clinical signs - GLP compliance:
- no
- Remarks:
- study conducted prior to implementation of GLP
- Test type:
- standard acute method
- Limit test:
- no
Test material
- Reference substance name:
- 2,2,4-trimethyl-1-oxa-4-aza-2-silacyclohexane
- EC Number:
- 233-487-5
- EC Name:
- 2,2,4-trimethyl-1-oxa-4-aza-2-silacyclohexane
- Cas Number:
- 10196-49-3
- Molecular formula:
- C6H15NOSi
- IUPAC Name:
- 2,2,4-trimethyl-1,4,2-oxazasilinane
Constituent 1
- Specific details on test material used for the study:
- OTHER SPECIFICS:
Kp. 140°C
technically pure
Test animals
- Species:
- rat
- Strain:
- Wistar
- Remarks:
- Wistar II
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Weight at study initiation: 170-205 g (males) and 180-200 g (females)
Please note: test results are also available for mouse, cat and dog.
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- water
- Details on oral exposure:
- VEHICLE
- Concentration in vehicle: not specified
- Amount of vehicle (if gavage): not specified
MAXIMUM DOSE VOLUME APPLIED: 1mL/100g bw - Doses:
- 50, 100, 250, 500, 1000, 1500, 1750, 2000, 2100, 2400, 2500 mg/kg bw (males)
250, 500, 1000, 1300, 1500, 2000, 2250 and 2500 mg/kg bw (females) - No. of animals per sex per dose:
- 15
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 7 days
- Statistics:
- The calculation of the average lethal dose was based on LITCHFIELD and WILCOXON, J. Pharmacol. exper. Therap. 96, 99 (1949).
Results and discussion
Effect levelsopen allclose all
- Key result
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- 1 890 mg/kg bw
- Based on:
- test mat.
- Key result
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- 1 645 mg/kg bw
- Based on:
- test mat.
- Mortality:
- Males:
The lowest lethal dose (3 deaths of 15 animals after 1-3 days) was 1750 mg/kg bw. 11 of 15 animals and 13 of 15 animals died at a dose of 2000 (within 1 day) and 2100 mg/kg bw (within 1-4 days), respectively. At doses 2400 and 2500 mg/kg bw all 15 animals in each dose group died within one day.
Females:
The lowest lethal dose (1 death of 15 animals after 1 day) was 1300 mg/kg bw. 4 of 15 animals and 13 of 15 animals died at a dose of 1500 (within 1 day) and 2000 mg/kg bw (within 1 day), respectively. At doses 2250 and 2500 mg/kg bw all 15 animals in each dose group died within one day. - Clinical signs:
- Poisoning signs such as breathing disorders, jumping cramps and reduction of the general condition were observed within 10 minutes (males) and 7 minutes (femlales) at a dose above or equal to 250 mg/kg bw and started within 2-3 minutes above or equal to 2000 (males) and 2250 (females) mg/kg bw. In animals, which did not die, clinical signs disappeared after 2-7 days (males) and 3-7 days (females).
Any other information on results incl. tables
| Number of animals dead [and with evident toxicity] [and time range within which mortality occurred] | |||||||
| Dose | Mortality (# dead/total) | Time range of deaths (hours) | Number with evident toxicity(#/total) | ||||
| (mg/kg bw) | Male | Female | Combined | Male | Female | Combined | |
| 50 | 0/15 | not tested | n/a | -- | 0/15 | not tested | n/a |
| 100 | 0/15 | not tested | n/a | -- | 0/15 | not tested | n/a |
| 250 | 0/15 | 0/15 | 0/30 | -- | 15/15 | 15/15 | 30/15 |
| 500 | 0/15 | 0/15 | 0/30 | -- | 15/15 | 15/15 | 30/15 |
| 1000 | 0/15 | 0/15 | 0/30 | -- | 15/15 | 15/15 | 30/15 |
| 1300 | not tested | 1/15 | n/a | 24 | not tested | 15/15 | n/a |
| 1500 | 0/15 | 4/15 | 4/30 | 24 | 15/15 | 15/15 | 30/15 |
| 1750 | 3/15 | not tested | n/a | 24-72 | 15/15 | not tested | n/a |
| 2000 | 11/15 | 13/15 | 24/30 | 24 | 15/15 | 15/15 | 30/15 |
| 2100 | 13/15 | not tested | n/a | 24-96 | 15/15 | not tested | n/a |
| 2250 | not tested | 15/15 | n/a | 24 | not tested | 15/15 | n/a |
| 2400 | 15/15 | not tested | n/a | 24 | 15/15 | not tested | n/a |
| 2500 | 15/15 | 15/15 | 30/30 | 24 | 15/15 | 15/15 | 30/15 |
Applicant's summary and conclusion
- Interpretation of results:
- Category 4 based on GHS criteria
- Conclusions:
- The oral LD50 of the test substance in male and female rats was 1890 and 1645 mg/kg bw, respectively.
- Executive summary:
In an acute oral toxicity study, 15 male and 15 female Wistar II strain rats per dose group were given a single oral dose of the test substance by gavage at a doses of 50, 100, 250, 500, 1000, 1500, 1750, 2000, 2100, 2400 and 2500 mg/kg bw (males) and 250, 500, 1000, 1300, 1500, 2000, 2250 and 2500 mg/kg bw (females) and were observed for 7 days.
Death in males started at a dose of 1750 mg/kg bw with 3/15 dead males within 1-3 days and death in females started at a dose of 1300 mg/kg bw with 1/15 dead female within 1 day. The LD50 was reported to be 1890 mg Aktiv. MO/kg bw (males) and 1645 mg Aktiv. MO/kg bw (females), respectively.
Clinical signs were breathing disorders, jumping cramps and reduction of the general condition within 10 minutes (males) and 7 minutes (females) at a dose above or equal to 250 mg/kg bw. linical signs were breathing disorders, jumping cramps and reduction of the general condition within 10 minutes (males) and 7 minutes (females) at a dose above or equal to 250 mg/kg bw.
The surviving animals had recovered from the symptoms until day 7.
Further results are available for mouse, cat and dog showing LD50 of >1000 mg/kg bw, 500 mg/kg bw and >250 mg/kg bw, respectively. However, the LD50 value for mice and dog are only estimates since the highest concentration used was 1000 mg/kg bw and 250 mg/kg bw. Furthermore, the total number of animals, i.e. 2 cats and 2 dogs, is not sufficient for a reliable dervation of a LD50 value and due to the preference of rats as suitable test animal for classification and labelling according to OECD guideline recommendation, the LD50 values in the present study report obtained with this species were used for classification and labelling according to regulation (EC) 1272/2008 (CLP).
Oral LD50 (rat, males/females) < 2000 mg/kg bw
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
